| Recruiting | High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors Germ Cell Tumor | Phase 2 | 2024-03-01 |
| Unknown | Sentinel Lymph Node Biopsy in Stage AI-IIA Germ Cell Tumors Testicular Germ Cell Tumor | N/A | 2023-11-08 |
| Recruiting | Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations RAS Mutation, Ras (Kras or Nras) Gene Mutation, Colorectal Cancer Recurrent | Phase 2 | 2023-10-03 |
| Active Not Recruiting | Survival Monitoring in Russian Cancer Registries Melanoma, Breast Cancer, Oncology | — | 2023-08-01 |
| Unknown | Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Colon Cancer Resections Versus no Bowel Preparation Colon Cancer | N/A | 2023-02-10 |
| Completed | ICG Fluorescence Guided Lymph Node Mapping for Determination of Bowel Resection Margins in Colon Cancer Colon Cancer | N/A | 2022-07-26 |
| Unknown | Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer HER2-positive Metastatic Breast Cancer, Oligometastatic Disease | N/A | 2022-07-01 |
| Unknown | Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After Surgery Bladder Cancer | Phase 3 | 2022-02-02 |
| Recruiting | Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas Bone Sarcoma, Embryonal Rhabdomyosarcoma, Alveolar Rhabdomyosarcoma | Phase 3 | 2021-05-20 |
| Unknown | Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Rectal Resections for Cancer Versus MBP Alone Rectal Cancer | N/A | 2020-10-30 |
| Unknown | Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer Ovarian Cancer | N/A | 2020-10-01 |
| Unknown | Clinical Validation of Cervical Cancer Screening Methods Cervical Cancer, Cervical Dysplasia, Human Papilloma Virus | — | 2020-07-13 |
| Recruiting | Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy Soft Tissue Sarcoma Adult | N/A | 2020-02-01 |
| Recruiting | Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadju Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNB | N/A | 2019-10-08 |
| Unknown | HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer Biochemical Relapse Free Survival, Complications Rates (Erectile Dysfunction, GI, GU Complications) | N/A | 2018-04-01 |
| Unknown | Study of Oncological Outcomes of D3 Lymph Node Dissection in Colon Cancer Colonic Neoplasms Malignant | N/A | 2017-02-03 |
| Unknown | Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer. Breast Cancer | Phase 2 | 2015-07-01 |
| Unknown | Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer Breast Cancer | Phase 2 | 2015-07-01 |
| Terminated | Comparison of Melatonin or Metformin and Dacarbazine Combination Versus Dacarbazine Alone in Disseminated Mela Melanoma | Phase 2 | 2014-04-01 |
| Enrolling By Invitation | BrEto-TCL - Defining the Role of Brentuximab and Etoposide for Optimizing First-line Therapy of T-cell Lymphom Peripheral T-cell Lymphoma | Phase 3 | 2013-10-01 |
| Unknown | Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma Sarcoma, Neoplasms, Connective and Soft Tissue | Phase 1 / Phase 2 | 2013-06-01 |
| Completed | CT Screening For Lung Cancer in High Risk Patients: the Russian Study. Lung Cancer | N/A | 2012-11-01 |
| Completed | Safety and Efficacy of Tag-7 Gene-modified Vaccine in Locally Advanced or Metastatic Malignant Melanoma or Kid Melanoma, Kidney Cancer | Phase 1 / Phase 2 | 2001-01-31 |
| Recruiting | Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research Malignant Solid Tumors, Primary Brain Tumor, Melanoma | — | 1998-09-01 |